FDA Opens Public Comments on Menopause Hormone Therapy Risks
The FDA opened a public docket for comments on menopause hormone therapy risks and benefits following expert panel discussions, with submissions closing Sept 24, 2025.
Removing Hormone Therapy Warnings, After Medical Experts Shocking Discovery
FDA experts urge removal of hormone therapy FDA black box warnings, citing outdated risks and benefits for menopausal women seeking treatment relief.